Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 281

Results For "LTI"

3159 News Found

Moderna and Carisma Therapeutics partner to develop CAR-M therapeutics
Biotech | January 10, 2022

Moderna and Carisma Therapeutics partner to develop CAR-M therapeutics

Carisma to receive US $ 45 million up-front cash payment and investment by Moderna in the form of a US $ 35 million convertible note


Novavax and Serum file EUA for Covovax in South Africa
Biotech | January 10, 2022

Novavax and Serum file EUA for Covovax in South Africa

Novavax' vaccine has received authorizations of the vaccine in over 170 countries


Indica Labs receive CE Mark for its HALO AP
Medical Device | January 10, 2022

Indica Labs receive CE Mark for its HALO AP

The HALO AP platform was developed by Indica Labs to address the specific needs of anatomic pathology labs by supporting a wide range of tissue-based workflows, including primary diagnosis, secondary consults, tumour boards, clinical trials, synoptic reporting, quantitative analytics, and AI


Exscientia and Sanofi collaborate for AI-driven precision-engineered medicine
Biotech | January 08, 2022

Exscientia and Sanofi collaborate for AI-driven precision-engineered medicine

Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform from target identification through patient selection. It will receive an upfront cash payment of US $ 100 million with the potential of US $ 5.2 billion in total milestones plus tiered royalties


Covaxin booster dose study shows promising results
News | January 08, 2022

Covaxin booster dose study shows promising results

Six months after receipt of the second Covaxin dose, participants received booster dose of the same. The trial demonstrated long-term safety with no serious events


AstraZeneca and Neurimmune to develop and commercialise NI006
Biotech | January 07, 2022

AstraZeneca and Neurimmune to develop and commercialise NI006

Investigational human monoclonal antibody in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy, a systemic, progressive and fatal condition


Merck KGaA to acquire biopharma CDMO Exelead for $780 million
Biotech | January 07, 2022

Merck KGaA to acquire biopharma CDMO Exelead for $780 million

The transaction is expected to close in the first quarter of 2022


Yashoda Hospitals performs region’s first double-lung transplant
Hospitals | January 06, 2022

Yashoda Hospitals performs region’s first double-lung transplant

After double lung transplantation, he was discharged without supplemental oxygen on the eleventh day


NATHEALTH Home Care Forum launches white paper on healthcare delivery
Healthcare | January 06, 2022

NATHEALTH Home Care Forum launches white paper on healthcare delivery

10 implementation focused initiatives recommended to accelerate policy reforms, standardization of home care delivery services, and improve accessibility and affordability of care in tier II and tier III geographies


Dr. K.V.S Ram Rao is the new JMD & CEO of Granules India
People | January 05, 2022

Dr. K.V.S Ram Rao is the new JMD & CEO of Granules India

He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management